Home > News
26.07.2024 - andera Life Sciences - Press releases
Andera Partners Co-Leads $196 Million Round for Kestra Medical and Welcomes Raymond W. Cohen to Boar…
25.07.2024 - andera Life Sciences - Press releases
Andera Partners’ portfolio company JenaValve Technology acquired by Edwards Lifesciences
25.07.2024 - andera Life Sciences - Press releases
Andera Partners’ portfolio company TRiCares secures $50 million in Series D Financing to Support Upc…
15.07.2024 - andera Life Sciences - Press releases
Andera Partners’ portfolio company Amolyt Pharma completes acquisition by AstraZeneca
09.07.2024 - andera Life Sciences - Press releases
Andera Partners co-leads a €63 million Series A round for Munich-based autoimmune biotech SciRhom
02.07.2024 - Andera Partners - Sustainability - Publications
2023 Sustainability Report
27.06.2024 - andera Expansion/Croissance - Press releases
Spengler Group takes on a European dimension with the acquisition of German manufacturer Luxamed
14.03.2024 - andera Life Sciences - Press releases
Andera Partners’ portfolio company Tubulis closes upsized €128 Million Series B2 to accelerate the d…
14.03.2024 - andera Life Sciences - Press releases
Amolyt Pharma, an Andera Partners’ portfolio company, announces its sale to AstraZeneca
28.02.2024 - andera Infra - Press releases
Andera Partners raises a final amount of € 233 million for Andera Smart Infra 1, its first fund dedi…
21.02.2024 - andera Life Sciences - Press releases
MMI Raises $110 Million in Series C Financing
12.02.2024 - andera Life Sciences - Recruitment
Internship Offer – Andera Life Sciences
12.02.2024 - Andera Partners - Press releases
2023 Report – After a record year of investments and exits, Andera Partners sets a target of 7…
24.01.2024 - andera Expansion/Croissance - Press releases
Meogroup initiates a new development cycle with the support of Andera Partners
23.01.2024 - Andera Partners - Press releases
Andera Partners welcomes Sophie ELKRIEF as Business Development Partner
18.01.2024 - andera MidCap - Press releases
Mistertemp’ group announces the reorganization of its shareholding: Andera Partners succeeds Montefi…
21.12.2023 - andera Infra - Press releases
Spanish energy transition developer INGENOSTRUM accelerates, with a fund raising of 25M€ from Andera…
14.12.2023 - andera Acto - Press releases
The Efor Group joins forces with the Nodarius Group, which includes the Altogen brand, to strengthen…
05.12.2023 - andera Acto - Press releases
The Imagerie Cardinet Group strengthens its position to accelerate its entrepreneurial model
30.11.2023 - andera Infra - News Infra - Press releases
mylight150 secures €100m to accelerate the expansion of its solar self-consumption & smart ener…
14.11.2023 - andera Life Sciences - Press releases
Andera Partners co-leads a €67.5 million ($72 million) oversubscribed Series C round for cancer immu…
13.11.2023 - andera Acto - Press releases
Andera Partners joins forces with Founders of Gosto Group in providing support in their internationa…
27.10.2023 - andera Life Sciences - Press releases
JenaValve Announces Late-Breaking Data from the ALIGN-AR Pivotal Trial Meeting Safety and Efficacy E…
11.10.2023 - andera Life Sciences - Press releases
Agomab Raises $100 Million Series C to Advance Fibrosis-focused Pipeline
10.10.2023 - andera Expansion/Croissance - Press releases
ELAN Languages acquires Dutch company AVB Vertalingen
05.10.2023 - andera Life Sciences - Press releases
Agomab Receives FDA Fast Track Designation for AGMB-129 in Fibrostenosing Crohn’s Disease and Starts…
05.10.2023 - andera Acto - Press releases
Andera Acto supports EFOR’s ambition of becoming a global leader in its market within five yea…
04.10.2023 - andera Acto - Press releases
Andera Partners completes full exit from Travelsoft Group and hands over to CAPZA
18.09.2023 - andera MidCap - Press releases
Andera Partners increases the hard cap for Andera MidCap 5 and raises a final amount of €750 million
24.07.2023 - andera Life Sciences - Press releases
Crescendo Biologics secures $32M and announces expansion of CB307 Phase 1b trial in PSMA+ solid tumo…
11.07.2023 - Andera Partners - Sustainability - Publications
2022 Sustainability Report
06.07.2023 - andera MidCap - Press releases
PAI Partners to acquire majority stake in Infra Group
04.07.2023 - andera Expansion/Croissance - Press releases
ELAN Languages completes acquisition of German group Lingua-World GmbH
29.06.2023 - andera Acto - Press releases
Andera Acto supports Auris Group in restructuring of its capital and in its development strategy
27.06.2023 - andera Life Sciences - Press releases
Allecra Therapeutics Submits New Drug Application to the U.S. FDA for EXBLIFEP® for the Treatment of…
19.06.2023 - andera Acto - Press releases
Siparex ETI finalises agreement to become majority shareholder of Passman group
14.06.2023 - andera MidCap - Press releases
Andera Partners and Pauwels Consulting management team join forces to accelerate the development of…
01.06.2023 - andera Life Sciences - Press releases
Inotrem announces publication of two key articles on nangibotide Phase II programs in peer-reviewed…
15.05.2023 - andera Life Sciences - Press releases
Andera Partners co-leads a €40 million Series A of Dualyx, a Belgian biotech developing novel Treg t…
10.05.2023 - Andera Partners - Press releases
Andera Partners appoints Stefan Keitel Senior Advisor DACH region further strengthening its presence…
25.04.2023 - andera Acto - Press releases
OneXillium group partners with Andera Acto to support them in their next development cycle
20.04.2023 - andera Life Sciences - Press releases
Tubulis Announces Strategic License Agreement with Bristol Myers Squibb to Develop Next Generation A…
18.04.2023 - andera Life Sciences - Press releases
Andera Partners co-leads a Series A extension round of € 47.75 million for radiopharmaceutical compa…
13.04.2023 - andera Life Sciences - Press releases
Andera Partners leads $48.5 Million Series A financing for medical device company BioVentrix®
05.04.2023 - andera Acto - Press releases
BEA Group (Andera Acto) expands in Italy, through acquisition of Capanna
29.03.2023 - andera Life Sciences - Press releases
Grey Wolf Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of GRWD5769 in…
22.03.2023 - andera Acto - Press releases
Andera Acto supports SPS Group, a member of the ECF network, in its capital restructuring
15.03.2023 - andera Life Sciences - Press releases
Andera Partners co-leads $25m extension round for FIRE1
15.03.2023 - andera Acto - Press releases
NG Travel Group chooses Andera Acto to support them in their capital restructuring
03.03.2023 - andera Life Sciences - Press releases
Flamingo Therapeutics and Dynacure Announce Merger to Create Leading RNA Therapeutics Company Focuse…
01.03.2023 - andera Acto - Press releases
Redslim partners with Andera Acto to support them in their next development cycle
16.02.2023 - Andera Partners - Press releases
2022 Report – Andera Partners
13.02.2023 - andera Life Sciences - Press releases
Andera Partners Portfolio Company Mineralys Therapeutics Successfully Completes Upsized $192 Million…
02.02.2023 - andera Life Sciences - Press releases
Agomab Reports Positive Phase 1 Results with AGMB-129, a GI-restricted ALK5 Inhibitor for Fibrosteno…
26.01.2023 - andera Life Sciences - Press releases
Andera Partners Participates in the €45 Million Series B Financing of Grey Wolf Therapeutics
23.01.2023 - andera MidCap - Press releases
Andera Partners reaches its €600 million target for Andera MidCap 5
10.01.2023 - andera Life Sciences - Press releases
Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatmen…
09.01.2023 - andera Life Sciences - Press releases
Andera Partners participates in the $138 Million Series C Financing of Amolyt Pharma
14.12.2022 - andera MidCap - Andera Partners - Press releases
Andera Partners opens its Milan office
25.10.2022 - andera MidCap - Press releases
KLUBB Group acquires Isoli S.p.A.
20.10.2022 - andera Life Sciences - Press releases
T-knife Therapeutics Announces Dosing of First Patient with TK-8001 in the IMAG1NE Phase 1/2 Clinica…
13.10.2022 - andera MidCap - Press releases
Andera Partners invests in a high-performance detection solutions company Senstronic
10.10.2022 - Andera Partners - Press releases
New governance for Andera Partners
10.10.2022 - andera Life Sciences - Press releases
Andera Partners raises its largest life sciences fund at €456M, demonstrating the attractiveness of…
04.10.2022 - andera Acto - Press releases
Ozitem chooses Andera Acto to support them in their capital restructuring
03.10.2022 - andera Life Sciences - Press releases
Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic…
16.09.2022 - andera Life Sciences - Press releases
JenaValve Completes Enrollment in the ALIGN-ARIDE Clinical Trial
15.09.2022 - andera Life Sciences - Press releases
TRiCares Raises €47m in a First Closing of its Series C
12.09.2022 - andera Life Sciences - Press releases
Agomab Therapeutics Selected as One of Fierce Biotech’s “Fierce 15” Companies of 2…
30.08.2022 - andera Infra - News Infra - Publications
French electric vehicle charging points market
30.08.2022 - andera Infra - News Infra - Publications
Maritim Mobility
30.08.2022 - andera Infra - News Infra - Publications
Datacenters
30.08.2022 - andera Infra - News Infra - Publications
Heat, the forsaken vector of a renewable future
30.08.2022 - andera Infra - News Infra - Publications
Green hydrogen will fuel tomorrow’s economy
20.07.2022 - andera Life Sciences - Press releases
Medical Microinstruments Secures $75M to Advance Robotic Microsurgery
13.07.2022 - andera Life Sciences - Press releases
Agomab Raises Additional $40.5 Million Through Series B Extension Bringing Total Amount to $114M
07.07.2022 - andera Life Sciences - Press releases
Andera Partners strengthens its Life Sciences team with a new partner
04.07.2022 - Sustainability - Publications
Annual CSR Report 2021 / Rapport Annuel RSE 2021
13.06.2022 - andera Life Sciences - Press releases
ImCheck Closes Upsized EUR 96 Million (USD 103 Million) Financing to Advance Clinical Validation of…
08.06.2022 - andera Life Sciences - Press releases
Andera Partners co-leads $118 Million Oversubscribed Series B Financing of Mineralys Therapeutics to…
17.05.2022 - andera Life Sciences - Press releases
TRiCares Announces Successful Implantation of Minimally Invasive Topaz Tricuspid Heart Valve Replace…
13.05.2022 - andera MidCap - Press releases
Andera Partners announces the intermediate closing of its new fund Andera MidCap 5 at €450m
11.05.2022 - andera MidCap - Press releases
HR Path receives €225 million in Financing
03.05.2022 - andera Life Sciences - Press releases
Andera Partners leads Tubulis’ €60 million Series B financing to advance its development of novel AD…
27.04.2022 - andera Expansion/Croissance - Press releases
Andera Partners to support ElaN Group, the leading technology platform for translation services in t…
26.04.2022 - andera Life Sciences - Press releases
Successful first in human implantation of Topaz Tricuspid Heart Valve Replacement System
07.04.2022 - andera Life Sciences - Press releases
Andera Partners to sell its Life Sciences’ portfolio company ReViral to Pfizer
01.04.2022 - andera Co-Invest - Press releases
Andera Partners and Compagnie Lebon launch a co-investment activity
31.03.2022 - Andera Partners - Press releases
Andera Partners announces two promotions to Partner and several appointments to strengthen its teams
22.03.2022 - andera Life Sciences - Press releases
Evommune Initiates Phase 1 Study to Evaluate Safety of EVO101, an IRAK4 Inhibitor, in Healthy Volunt…
24.02.2022 - Andera Partners - Press releases
Andera Partners creates Andera Partners Transformation A unique support platform in private equity i…
22.02.2022 - andera Life Sciences - Press releases
Andera Partners supports TargED Biopharmaceuticals in €39 million Series A financing to bring ground…
17.02.2022 - Andera Partners - Press releases
With nearly €550 million deployed, Andera Partners experienced a record year in 2021
03.02.2022 - andera Infra - Press releases
Andera Partners invests in green renewable hydrogen production company Lhyfe
19.01.2022 - andera Life Sciences - Press releases
JenaValve Announces Strategic Investment and Licensing Agreement with Peijia Medical Limited
13.01.2022 - andera Life Sciences - Press releases
Allecra Therapeutics and ADVANZ PHARMA Sign Exclusive License and Supply Agreement for Allecra’s Ant…
10.01.2022 - andera Life Sciences - Press releases
BioNTech and Crescendo Biologics announce global collaboration to develop multi-specific precision i…
09.12.2021 - andera Infra - Press releases
Andera Partners announces 1st closing at €84m for Andera Smart Infra 1
22.11.2021 - andera Life Sciences - Press releases
Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology
15.11.2021 - andera Acto - Press releases
Andera Partners supports the Founder of ENACO Group in the acquisition of its entire share capital a…
28.10.2021 - andera Life Sciences - Press releases
Agomab Therapeutics to Acquire Origo Biopharma
26.10.2021 - andera Life Sciences - Press releases
Andera Partners supports Exciva in a Series A to fight Alzheimer’s disease
29.09.2021 - Andera Partners - Publications
The role of private equity in the recovery in France and Europe: an opportunity for investors
16.09.2021 - andera Life Sciences - Press releases
Andera Partners leads Amolyt Pharma’s $80 million Series B alongside Sectoral Asset Management
10.09.2021 - andera Acto - Press releases
Andera Acto supports DP Software Group in its development strategy
09.09.2021 - andera Life Sciences - Press releases
Andera Partners leads US$ 83 million series A round in Evommune Inc. for the development of transfor…
08.09.2021 - Andera Partners - Press releases
Andera Partners strengthens its investment teams and reaffirms its growth ambition
02.08.2021 - andera Life Sciences - Press releases
T-knife Announces $110 Million Series B Financing to Advance Pipeline of T-cell Receptor Therapies
27.07.2021 - andera Life Sciences - Press releases
Artios Pharma has completed a $153 million series C
26.07.2021 - andera MidCap - Press releases
Andera Partners and the KLUBB Group’s founder join forces
23.07.2021 - Sustainability - Press releases
Andera Partners publishes its first Climate & Sustainability Report
22.07.2021 - andera Expansion/Croissance - Press releases
Andera Expansion acquires MC2 Technologies
08.07.2021 - andera MidCap - Press releases
Andera Partners sells its majority stake in Infra Group
06.07.2021 - andera MidCap - Press releases
Andera MidCap sells its stake in Minafin
05.07.2021 - andera Life Sciences - Press releases
TRiCares announces the successful first in human implantations of “Topaz”
23.06.2021 - andera Life Sciences - Press releases
Poxel announces the approval of Twymeeg
18.06.2021 - andera MidCap - Press releases
Andera sells its stake in Netco Group
04.05.2021 - andera Life Sciences - Press releases
Life Sciences portfolio company Gamamabs signs an agreement with Exelixis
27.04.2021 - andera Life Sciences - Andera Partners - Press releases
Andera Partners strengthens its presence in the DACH region
13.04.2021 - andera Infra
Internship offer – Infrastructure investment
07.04.2021 - andera Life Sciences
Artios Pharma announces collaboration with Novartis
06.04.2021 - Andera Partners - Press releases
Andera creates its own foundation
09.03.2021 - Andera Partners - Press releases
Andera Partners announces the arrival of Noëlla de Bermingham as Chief Sustainability Officer
02.03.2021 - andera Life Sciences - Press releases
ReViral and LianBio Announce Exclusive Collaboration
26.02.2021 - andera MidCap - Press releases
Pusterla 1880 issues Sustainability-Linked Bonds to finance its growth
16.02.2021 - andera Infra - Andera Partners - Press releases
Our 5th area of activity: Andera Infra
10.02.2021 - andera Life Sciences - Press releases
MedLumics closes upsized EUR 18M financing round and appoints new Chairman
05.02.2021 - Andera Partners - Press releases
Andera strengthens governance and targets €4-5 billion in AUM by 2025
04.02.2021 - andera MidCap - Press releases
Andera MidCap sells Skill & You to IK Investment Partners
13.01.2021 - andera Life Sciences
MMI appoints healthcare industry veteran Mark Toland as CEO
12.01.2021 - andera MidCap - Press releases
Andera MidCap invests in Pusterla 1880
07.01.2021 - andera Life Sciences - Press releases
AM-Pharma Announces Enrollment and Financing of COVID-19 Cohort in Phase III REVIVAL Trial
05.01.2021 - andera Life Sciences - Press releases
Andera sells its Life Sciences’ portfolio company Arvelle Therapeutics
04.01.2021 - andera Life Sciences - Press releases
Inotrem’s COVID-19 Phase IIa Clinical Trial declared “National Priority Research” by the French gove…
21.12.2020 - Uncategorized - Press releases
Significant agreements with Chinese market leaders in our Life Sciences portfolio
01.12.2020 - Andera Partners - Press releases
Andera Partners renames all its activities
21.10.2020 - Andera Partners - Press releases
The Power of And
12.10.2020 - andera Life Sciences - Press releases
Medlumics lands a 14M€ new financing round
28.08.2020 - andera Life Sciences - Press releases
Reviral raises $44 million in Series C financing
06.08.2020 - andera Life Sciences - Press releases
T-knife completes €66m Series A financing
23.07.2020 - andera Life Sciences - Press reviews
COVID-19: assessing nangibotide in mechanically ventilated patients with COVID-19
29.06.2020 - andera Acto - Press releases
ActoMezz IV: a single closing at more than €500 million
11.06.2020 - andera Life Sciences - Press releases
BioDiscovery sells Corvidia to Novo Nordisk
06.05.2020 - andera Life Sciences - Press releases
Appointment of Michael H. Carrel as chairman of the Axonics board of directors.
06.05.2020 - andera Life Sciences - Press releases
Axonics Modulation Technologies reports financial results for the 1st quarter 2020 and provides an…
02.04.2020 - andera Life Sciences - Press releases
Dynacure Announces €50M ($55M) Series C Financing
01.04.2020 - andera Life Sciences - Press releases
AM-Pharma Increases Funding to €163m for Phase-III Trial of recAP in SA-AKI
05.03.2020 - Andera Partners - Publications
Newsletter – 03/2020
28.02.2020 - andera Life Sciences - Press releases
Allecra Therapeutics announces positive top-Line results for phase 3 ALLIUM clinical trial of EXBLIF…
27.02.2020 - Andera Partners - Press releases
2019: a new record year for Andera
21.11.2019 - andera Life Sciences - Press releases
Inotrem Announces Enrollment of First Patient in its Phase IIb Trial in the Treatment of Septic Shoc…
14.10.2019 - andera Expansion/Croissance - Press releases
Hans Van de Velde – Senior Advisor Belgium
11.10.2019 - andera Life Sciences - Press releases
BioDiscovery invests in AgomAb Therapeutics
16.07.2019 - andera Life Sciences - Press releases
BioDiscovery co-leads $133 million Financing in AM-Pharma B.V.
02.07.2019 - andera Expansion/Croissance - Press releases
The ORCA Group acquires Italian companies Angeloni and Impregnatex
01.07.2019 - Andera Partners - Publications
ic20: Initiative Climate 2020
15.05.2019 - andera MidCap - Press releases
Winch invests in Spherea
05.04.2019 - andera MidCap - Press releases
Winch invests in the Belgian company Infra Group
03.04.2019 - andera Acto - Press releases
ActoMezz invests in Tournus
28.03.2019 - Andera Partners - Press releases
Appointments and Recruitments
14.02.2019 - andera Life Sciences - Press releases
A syndicate of international investors finance Arvelle Therapeutics
11.02.2019 - andera Life Sciences - Press releases
Grey Wolf Therapeutics completes £10 million series A financing with Andera Partners and Canaan
28.01.2019 - andera MidCap - Press releases
NetCo welcomes IK among its shareholders, alongside Andera and the founding family
18.01.2019 - Andera Partners - Press releases
2018: an emblematic year for Andera Partners
03.12.2018 - andera MidCap - Press releases
Winch Capital 4: fundraising completed at €445 million
05.11.2018 - andera Life Sciences - Press releases
Crescendo Biologics announces early licensing by Takeda
05.11.2018 - andera Life Sciences - Press releases
Promising results for the lead program of Genkyotex (BioDiscovery 3) in a fibrotic orphan disease
02.08.2018 - andera Life Sciences - Press releases
Artios Pharma Announces $86 million (£65 million) Series B Financing
18.07.2018 - andera MidCap - Press releases
WINCH Capital 4: a first closing of €360m for Andera Partners mid-cap fund
06.07.2018 - andera Life Sciences - Press releases
BioDiscovery invests in Dynacure to advance lead program into clinical development
04.07.2018 - Andera Partners - Press releases
Renewed governance for Andera Partners
04.06.2018 - andera Life Sciences - Press releases
ENYO Pharma raises €40 million in Series B fundraising
04.06.2018 - andera Life Sciences - Press releases
TRiCares Closes €22 Million ($25.4 Million) Series B Financing Round to Fund Development of Minimall…
22.05.2018 - andera Life Sciences - Press releases
GamaMabs Pharma to present at 2018 ASCO annual meeting results from the First-In-Human clinical stud…
02.05.2018 - andera Life Sciences - Press releases
Crescendo Biologics Ltd. raises $70 Million (€57 Million) in Series B financing
26.04.2018 - andera MidCap - Press releases
Andera Partners sponsors the carve-out of Conduent’s Off-Street Parking business in association with…
25.04.2018 - andera Life Sciences - Press releases
Corvidia Therapeutics Secures $60 Million in Series B Funding
04.04.2018 - Andera Partners - Press releases
EdRIP becomes ANDERA PARTNERS
Vous souhaitez obtenir des informations sur Andera Partners et ses activités ?
Contactez-nous